Merida Biosciences

Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. The company's platform focuses on the selective elimination of disease-causing antibody-producing ...

Healthcare

Cambridge, MA, United States

Founded 2022

45 employees

Website

Valuation

$228M

Market implied

Share Price

N/A

Total Raised

$154M

Last Round

N/A

Investors

+6 other investors

View all 6 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Merida Biosciences's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required